您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > CHZ868
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
CHZ868
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CHZ868图片
CAS NO:1895895-38-1
包装:100 mg
市场价:11667元

产品介绍

产品描述

CHZ868 is a type II JAK2 inhibitor (IC50: 0.17 μM in EPOR JAK2 WT Ba/F3 cell).

体外活性

CHZ868 potently inhibits constitutive STAT5 and JAK2 phosphorylation in JAK2V617F SET2 cells. CHZ868 potently inhibits the proliferation of SET2 cells (GI50: 59 nM) and has 6-fold less growth inhibitory activity against CMK cells (GI50: 378 nM) [1]. At 100 nM CHZ868 has activity against 26 kinases, including JAK2 and TYK2. CHZ868 potently suppresses the growth of CRLF2-rearranged human B-ALL cells, abrogates JAK2 signaling [2].

体内活性

CHZ868 is characterized by good metabolic stability, and low water solubility, as well as by moderate blood clearance and good oral bioavailability. CHZ868 improves survival in mice with human or murine B-ALL. CHZ868 and dexamethasone synergistically induce apoptosis in JAK2-dependent B-ALLs and further improves survival compared to CHZ868 alone [2].

细胞实验

CHZ868 is dissolved in DMSO to make 10 mM stock solution and diluted in culture media. Cells are treated with CHZ868 (0, 0.05, 0.1, 0.2 μM) or vehicle (DMSO). After 48 hr (Ba/F3 cells) or 72 hr (MHH-CALL4 and PDX cells), CellTiter-Glo Luminescent Cell Viability Assay is added (10 μL undiluted or 25 μL of a 1:2 dilution in each well) and plates are read [2].

动物实验

CHZ868 is reconstituted in 0.5% methylcellulose / 0.5% Tween-80 and administered at doses of 10 or 30 mg/kg/day by oral gavage. Pharmacokinetic/pharmacodynamic and efficacy studies in the mouse model of rhEpo-induced polycythemia are carried out essentially. Detection of STAT5 phosphorylation in spleen lysates by Meso Scale Discovery is performed [2].

Cas No.

1895895-38-1

分子式

C22H19F2N5O2

分子量

423.42

储存和溶解度

DMSO:145 mg/mL (342.45 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years